NURS 6521 Midterm Exam (4 Versions, 400 Q and A,
Year-2021) / NURS 6521N Midterm Exam / NURS6521
Midterm Exam / NURS-6521N Midterm Exam: Walden
University | Correct Q and A
1. A nurse practitioner is teaching a patient about how the body processes a newly prescribed
medication. Which statement best describes pharmacokinetics?
A. “Pharmacokinetics is the study of how the drug affects the body’s receptors.”
B. “Pharmacokinetics is the study of how the body absorbs, distributes, metabolizes, and
excretes the drug.”
C. “Pharmacokinetics is the study of drug interactions with other medications.”
D. “Pharmacokinetics is the study of the therapeutic effects of the drug.”
Correct Answer: B
Rationale: Pharmacokinetics describes what the body does to a drug through absorption,
distribution, metabolism, and excretion (ADME). Pharmacodynamics describes what the drug
does to the body .
2. A patient is prescribed a medication that undergoes extensive first-pass metabolism. The
nurse practitioner should understand that this medication will:
A. Have high oral bioavailability
B. Have low oral bioavailability and may require a higher oral dose
C. Be rapidly excreted unchanged by the kidneys
D. Have no adverse effects
Correct Answer: B
Rationale: Drugs with extensive first-pass metabolism have low oral bioavailability because
a significant portion is metabolized by the liver before reaching systemic circulation. Higher oral
doses or alternative routes (IV, sublingual) may be needed .
3. A medication has a half-life of 8 hours. Approximately how long will it take to reach steady-
state plasma concentration?
,A. 8 hours
B. 16 hours
C. 32 hours
D. 64 hours
Correct Answer: C
Rationale: Steady state is reached after 4–5 half-lives. 8 hours × 4 = 32 hours. At steady
state, drug administration rate equals drug elimination rate .
4. A patient taking a highly protein-bound drug develops severe hypoalbuminemia. What is
the most clinically important consequence?
A. The unbound active fraction of the drug may rise, increasing toxicity risk
B. The drug will be unable to be absorbed
C. The drug’s half-life will become zero
D. All receptors will become inactive
Correct Answer: A
Rationale: Reduced albumin increases free drug for highly protein-bound agents, raising
pharmacologic effect and toxicity risk. This is particularly important for drugs with narrow
therapeutic indices .
5. Which enzyme system is responsible for many phase I oxidative drug interactions?
A. Cyclooxygenase-1
B. Cytochrome P450
C. Acetylcholinesterase
D. Factor Xa
Correct Answer: B
Rationale: Cytochrome P450 enzymes metabolize many drugs and are affected by
inhibitors, inducers, and genetic variation. This system is central to understanding drug-drug
interactions .
6. Which statement best describes zero-order elimination?
,A. A fixed fraction of the drug is eliminated per unit time
B. Drug elimination never saturates
C. A fixed amount of drug is eliminated per unit time
D. Only the kidney can eliminate the drug
Correct Answer: C
Rationale: Zero-order elimination occurs when metabolic capacity is saturated, so the same
amount is removed over time regardless of concentration. Ethanol and high-dose phenytoin are
classic examples .
7. A drug that binds to a receptor and activates a response is called:
A. An antagonist
B. An agonist
C. A partial agonist
D. A competitive inhibitor
Correct Answer: B
Rationale: An agonist binds to a receptor and activates a response. An antagonist binds but
does not activate a response (blocks the receptor). A partial agonist produces a partial
response .
8. A patient with decreased kidney function is prescribed a renally eliminated medication. The
provider should anticipate:
A. Increasing the dose
B. Shortening the dosing interval
C. Reducing the dose or increasing the dosing interval
D. Discontinuing all medications
Correct Answer: C
Rationale: Reduced renal clearance can cause medication accumulation and toxicity. Dose
reduction or extended dosing intervals are necessary to maintain safe serum levels .
9. Drug efficacy refers to:
, A. The speed at which a drug is absorbed
B. The maximum therapeutic effect a drug can produce
C. The amount of drug bound to protein
D. The drug’s elimination half-life
Correct Answer: B
Rationale: Efficacy is the greatest effect a medication can achieve regardless of dose.
Potency refers to the amount of drug needed to produce a given effect .
10. A patient taking two highly protein-bound medications develops signs of toxicity. The
provider suspects:
A. Increased renal filtration
B. Protein-binding displacement
C. Reduced absorption
D. Increased metabolism
Correct Answer: B
Rationale: When drugs compete for protein binding sites, more free active drug may
circulate, increasing toxicity risk. This is a classic drug-drug interaction mechanism .
11. Which patient factor has the greatest effect on medication clearance?
A. Eye color
B. Blood type
C. Kidney and liver function
D. Hair color
Correct Answer: C
Rationale: The liver and kidneys are primary organs responsible for metabolism and
elimination. Renal or hepatic impairment significantly alters drug clearance .
12. A patient develops angioedema while taking lisinopril. The provider should recognize this
as:
Year-2021) / NURS 6521N Midterm Exam / NURS6521
Midterm Exam / NURS-6521N Midterm Exam: Walden
University | Correct Q and A
1. A nurse practitioner is teaching a patient about how the body processes a newly prescribed
medication. Which statement best describes pharmacokinetics?
A. “Pharmacokinetics is the study of how the drug affects the body’s receptors.”
B. “Pharmacokinetics is the study of how the body absorbs, distributes, metabolizes, and
excretes the drug.”
C. “Pharmacokinetics is the study of drug interactions with other medications.”
D. “Pharmacokinetics is the study of the therapeutic effects of the drug.”
Correct Answer: B
Rationale: Pharmacokinetics describes what the body does to a drug through absorption,
distribution, metabolism, and excretion (ADME). Pharmacodynamics describes what the drug
does to the body .
2. A patient is prescribed a medication that undergoes extensive first-pass metabolism. The
nurse practitioner should understand that this medication will:
A. Have high oral bioavailability
B. Have low oral bioavailability and may require a higher oral dose
C. Be rapidly excreted unchanged by the kidneys
D. Have no adverse effects
Correct Answer: B
Rationale: Drugs with extensive first-pass metabolism have low oral bioavailability because
a significant portion is metabolized by the liver before reaching systemic circulation. Higher oral
doses or alternative routes (IV, sublingual) may be needed .
3. A medication has a half-life of 8 hours. Approximately how long will it take to reach steady-
state plasma concentration?
,A. 8 hours
B. 16 hours
C. 32 hours
D. 64 hours
Correct Answer: C
Rationale: Steady state is reached after 4–5 half-lives. 8 hours × 4 = 32 hours. At steady
state, drug administration rate equals drug elimination rate .
4. A patient taking a highly protein-bound drug develops severe hypoalbuminemia. What is
the most clinically important consequence?
A. The unbound active fraction of the drug may rise, increasing toxicity risk
B. The drug will be unable to be absorbed
C. The drug’s half-life will become zero
D. All receptors will become inactive
Correct Answer: A
Rationale: Reduced albumin increases free drug for highly protein-bound agents, raising
pharmacologic effect and toxicity risk. This is particularly important for drugs with narrow
therapeutic indices .
5. Which enzyme system is responsible for many phase I oxidative drug interactions?
A. Cyclooxygenase-1
B. Cytochrome P450
C. Acetylcholinesterase
D. Factor Xa
Correct Answer: B
Rationale: Cytochrome P450 enzymes metabolize many drugs and are affected by
inhibitors, inducers, and genetic variation. This system is central to understanding drug-drug
interactions .
6. Which statement best describes zero-order elimination?
,A. A fixed fraction of the drug is eliminated per unit time
B. Drug elimination never saturates
C. A fixed amount of drug is eliminated per unit time
D. Only the kidney can eliminate the drug
Correct Answer: C
Rationale: Zero-order elimination occurs when metabolic capacity is saturated, so the same
amount is removed over time regardless of concentration. Ethanol and high-dose phenytoin are
classic examples .
7. A drug that binds to a receptor and activates a response is called:
A. An antagonist
B. An agonist
C. A partial agonist
D. A competitive inhibitor
Correct Answer: B
Rationale: An agonist binds to a receptor and activates a response. An antagonist binds but
does not activate a response (blocks the receptor). A partial agonist produces a partial
response .
8. A patient with decreased kidney function is prescribed a renally eliminated medication. The
provider should anticipate:
A. Increasing the dose
B. Shortening the dosing interval
C. Reducing the dose or increasing the dosing interval
D. Discontinuing all medications
Correct Answer: C
Rationale: Reduced renal clearance can cause medication accumulation and toxicity. Dose
reduction or extended dosing intervals are necessary to maintain safe serum levels .
9. Drug efficacy refers to:
, A. The speed at which a drug is absorbed
B. The maximum therapeutic effect a drug can produce
C. The amount of drug bound to protein
D. The drug’s elimination half-life
Correct Answer: B
Rationale: Efficacy is the greatest effect a medication can achieve regardless of dose.
Potency refers to the amount of drug needed to produce a given effect .
10. A patient taking two highly protein-bound medications develops signs of toxicity. The
provider suspects:
A. Increased renal filtration
B. Protein-binding displacement
C. Reduced absorption
D. Increased metabolism
Correct Answer: B
Rationale: When drugs compete for protein binding sites, more free active drug may
circulate, increasing toxicity risk. This is a classic drug-drug interaction mechanism .
11. Which patient factor has the greatest effect on medication clearance?
A. Eye color
B. Blood type
C. Kidney and liver function
D. Hair color
Correct Answer: C
Rationale: The liver and kidneys are primary organs responsible for metabolism and
elimination. Renal or hepatic impairment significantly alters drug clearance .
12. A patient develops angioedema while taking lisinopril. The provider should recognize this
as:
